Maze Therapeutics Growth Metrics (2024-2026) | MAZE

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin (QoQ) (Quarter) -106220.00101,906.00
EBIT Margin (QoQ) (Quarter) -106220.00101,906.00
EBT Margin (QoQ) (Quarter) -109509.00102,082.00
Enterprise Value Growth (1y) (Quarter) -880.49%-51.09%-156.63%-73.73%-19.71%
Enterprise Value (QoQ) (Quarter) -483.10%14.54%-31.55%-49.57%10.15%-45.16%10.94%-3.06%
FCF Margin (QoQ) (Quarter) -102876.0094,744.00
Net Margin (QoQ) (Quarter) -99934.0099,377.00
Operating Margin (QoQ) (Quarter) -106220.00101,906.00
Return on Assets Growth (1y) (Quarter) 0.00
Return on Assets (QoQ) (Quarter) -1.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -3605.00
Return on Capital Employed (QoQ) (Quarter) -5916.00462.001,619.00230.00
Return on Equity Growth (1y) (Quarter) 0.005.00
Return on Equity (QoQ) (Quarter) -5.005.000.000.000.00
Return on Invested Capital (QoQ) (Quarter) 0.000.00
Return on Sales Growth (1y) (Quarter) 0.0011.00
Return on Sales (QoQ) (Quarter) -11.0010.000.00